Elevance Health Inc (NYSE: ELV) kicked off on Friday, up 1.19% from the previous trading day, before settling in for the closing price of $525.19. Over the past 52 weeks, ELV has traded in a range of $412.00-$539.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 13.24% over the last five years. While this was happening, its average annual earnings per share was recorded 12.37%. With a float of $231.25 million, this company’s outstanding shares have now reached $233.07 million.
The firm has a total of 104900 workers. Let’s measure their productivity.
Elevance Health Inc (ELV) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Elevance Health Inc is 0.50%, while institutional ownership is 91.78%. The most recent insider transaction that took place on Mar 08 ’24, was worth 1,217,119. In this transaction EVP & President, Commercial of this company sold 2,432 shares at a rate of $500.46, taking the stock ownership to the 15,840 shares. Before that another transaction happened on Mar 06 ’24, when Company’s CAO & Controller sold 916 for $504.58, making the entire transaction worth $462,195. This insider now owns 1,764 shares in total.
Elevance Health Inc (ELV) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 12.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.10% during the next five years compared to 12.18% growth over the previous five years of trading.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Take a look at Elevance Health Inc’s (ELV) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.72. Likewise, its price to free cash flow for the trailing twelve months is 53.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 26.46, a number that is poised to hit 10.04 in the next quarter and is forecasted to reach 41.61 in one year’s time.
Technical Analysis of Elevance Health Inc (ELV)
Analysing the last 5-days average volume posted by the [Elevance Health Inc, ELV], we can find that recorded value of 1.59 million was better than the volume posted last year of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 74.79%. Additionally, its Average True Range was 9.98.
During the past 100 days, Elevance Health Inc’s (ELV) raw stochastic average was set at 91.46%, which indicates a significant increase from 83.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.30% in the past 14 days, which was higher than the 16.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $508.67, while its 200-day Moving Average is $473.94. Now, the first resistance to watch is $536.35. This is followed by the second major resistance level at $541.27. The third major resistance level sits at $546.50. If the price goes on to break the first support level at $526.20, it is likely to go to the next support level at $520.97. Should the price break the second support level, the third support level stands at $516.05.
Elevance Health Inc (NYSE: ELV) Key Stats
The company with the Market Capitalisation of 123.51 billion has total of 232,700K Shares Outstanding. Its annual sales at the moment are 171,340 M in contrast with the sum of 5,987 M annual income. Company’s last quarter sales were recorded 42,647 M and last quarter income was 856,000 K.
